In this study, Eμ-TCL1 mice with constitutive AID overexpression driven by the actin or Ig kappa promoter can acquire off-target mutations in oncogenes and tumor suppressors in CLL cells, leading to aggressive progression of CLL in these models. Here, AICDA is linked to B-cell chronic lymphocytic leukemia.